About Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. is a publicly traded company listed on a major US stock exchange under the ticker symbol CLBT. All of Cellebrite DI Ltd.'s regulatory filings are tracked under CIK number 0001854587 in the SEC EDGAR (Electronic Data Gathering, Analysis, and Retrieval) system — the official database of the U.S. Securities and Exchange Commission.
According to SEC regulations, all publicly traded companies in the United States are required to file periodic reports disclosing their financial condition, operating results, and material business events. This page aggregates Cellebrite DI Ltd.'s most recent filings in one place.
Why Review CLBT SEC Filings?
SEC filings are the most authoritative and legally binding source of financial information for any publicly traded company. Unlike earnings calls, press releases, or third-party analyst reports, SEC filings are required by law to be accurate, complete, and not misleading — under penalty of securities fraud (Section 10(b) of the Securities Exchange Act of 1934).
For investors researching Cellebrite DI Ltd. (CLBT), the key filing types include:
- 10-K Annual Reports — Comprehensive yearly financial overview with audited statements, risk factors, and management discussion & analysis (MD&A). Filed once per fiscal year.
- 10-Q Quarterly Reports — Unaudited quarterly financial data showing performance trends, filed three times per year during non-annual quarters.